Monday, November 21, 2016

BRIEF-Mallinckrodt will initiate company-sponsored clinical trial of h.p. acthar gel in treatment of amyotropic lateral sclerosis

* Says U.S. Fda has granted co's request for a fast track

designation for its acthar investigational new drug (IND)

application in patients with ALS

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)